SELP and Hypercholesterolemia: In all hypercholesterolemia patients, decreased platelet membrane expression of CD62P and plasma levels of the in vivo platelet activation markers (soluble CD40 Ligand, Platelet Factor-4, and soluble P-Selectin) were observed [58].